Commentary on: Risk Factors and Characteristics of Recalcitrant Osteomyelitis Following Initial Surgical and Antibiotic Treatment

J Orthop Trauma. 2023 Sep 1;37(9):423. doi: 10.1097/BOT.0000000000002652.
No abstract available

Publication types

  • Comment

MeSH terms

  • Anti-Bacterial Agents* / therapeutic use
  • Humans
  • Osteomyelitis* / diagnosis
  • Osteomyelitis* / drug therapy
  • Osteomyelitis* / etiology
  • Risk Factors

Substances

  • Anti-Bacterial Agents